Ryan Chavez was appointed CFO in November 2016 after joining Asterias in July 2016 as Executive Vice President of Finance and General Counsel. Prior to joining Asterias, Ryan was Vice President and General Counsel of Mallinckrodt Pharmaceuticals' Autoimmune and Rare Diseases Business, a position he held following Mallinckrodt's merger with Questcor Pharmaceuticals in August 2014. Before joining Mallinckrodt, Ryan served as Associate General Counsel for Questcor. Prior to joining Questcor in October 2012, Ryan held corporate attorney positions at the law firms Stradling Yocca Carlson & Rauth and Rutan & Tucker, LLP. Previously, Ryan served in various financial roles with General Electric Co. Ryan earned his J.D., magna cum laude, from Chapman Law School and his B.A., with honors and distinction, from Stanford University.